Literature DB >> 32374363

Association of Topical Corticosteroids With Reduced Vulvar Squamous Cell Carcinoma Recurrence in Patients With Vulvar Lichen Sclerosus.

Simone Chin1,2,3, James Scurry4,5, Jennifer Bradford3, Geoffrey Lee3, Gayle Fischer3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32374363      PMCID： PMC7203667          DOI： 10.1001/jamadermatol.2020.1074

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN： 2168-6068            Impact factor:   10.282


× No keyword cloud information.
  6 in total

1.  Adjacent Lichen Sclerosis predicts local recurrence and second field tumour in women with vulvar squamous cell carcinoma.

Authors:  J K W Yap; R Fox; S Leonard; R Ganesan; S T Kehoe; C W Dawson; C B Woodman; D M Luesley
Journal:  Gynecol Oncol       Date:  2016-07-07       Impact factor: 5.482

2.  Residual anogenital lichen sclerosus after cancer surgery has a high risk for recurrence: a clinicopathological study of 75 women.

Authors:  Sigrid Regauer
Journal:  Gynecol Oncol       Date:  2011-07-29       Impact factor: 5.482

3.  Long-term Management of Adult Vulvar Lichen Sclerosus: A Prospective Cohort Study of 507 Women.

Authors:  Andrew Lee; Jennifer Bradford; Gayle Fischer
Journal:  JAMA Dermatol       Date:  2015-10       Impact factor: 10.282

4.  Lichen sclerosus and risk of cancer.

Authors:  Pia Halonen; Maija Jakobsson; Oskari Heikinheimo; Annika Riska; Mika Gissler; Eero Pukkala
Journal:  Int J Cancer       Date:  2017-02-10       Impact factor: 7.396

5.  Lichen Sclerosus: Incidence and Risk of Vulvar Squamous Cell Carcinoma.

Authors:  Maaike C G Bleeker; Pascal J Visser; Lucy I H Overbeek; Marc van Beurden; Johannes Berkhof
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-06-02       Impact factor: 4.254

6.  A survey on the use of topical steroids in patients treated for lichen sclerosus-associated vulval squamous cell carcinoma.

Authors:  Rachel Pounds; Sanna Tahir; Christopher Dawson; Ciaran Woodman; David Luesley; Jason Yap
Journal:  J Obstet Gynaecol       Date:  2017-10-10       Impact factor: 1.246
  6 in total
  3 in total

1.  The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) Consensus Statements on Pre-invasive Vulvar Lesions.

Authors:  Mario Preti; Elmar Joura; Pedro Vieira-Baptista; Marc Van Beurden; Federica Bevilacqua; Maaike C G Bleeker; Jacob Bornstein; Xavier Carcopino; Cyrus Chargari; Margaret E Cruickshank; Bilal Emre Erzeneoglu; Niccolò Gallio; Debra Heller; Vesna Kesic; Olaf Reich; Colleen K Stockdale; Bilal Esat Temiz; Linn Woelber; François Planchamp; Jana Zodzika; Denis Querleu; Murat Gultekin
Journal:  J Low Genit Tract Dis       Date:  2022-06-21       Impact factor: 3.842

2.  Does longer duration of corticosteroid treatment improve clearance in vulvar lichen sclerosus? Results from a single centre, comparative, open label study.

Authors:  Monica Corazza; Giulia Toni; Giorgia Valpiani; Chiara Morotti; Alessandro Borghi
Journal:  Dermatol Ther       Date:  2021-05-04       Impact factor: 2.851

3.  Clinicopathologic Diagnosis of Differentiated Vulvar Intraepithelial Neoplasia and Vulvar Aberrant Maturation.

Authors:  Tania Day; Alexandra Marzol; Ross Pagano; Ken Jaaback; James Scurry
Journal:  J Low Genit Tract Dis       Date:  2020-10       Impact factor: 3.842
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.